Article
Publicly Available
Frontmatter
Published/Copyright:
April 4, 2023
Published Online: 2023-04-04
©2023 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Review
- Determining a minimum data set for reporting clinical and radiologic data for pseudomyxoma peritonei
- Research Articles
- Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study
- A study of somatic BRCA variants and their putative effect on protein properties in malignant mesothelioma
- Survival benefits with EPIC in addition to HIPEC for low grade appendiceal neoplasms with pseudomyxoma peritonei: a propensity score matched study
- Histological tumor response predicts clinical outcome in patients with colorectal peritoneal metastasis treated with preoperative chemotherapy followed by cytoreduction and HIPEC
- Congress Abstracts
- ISSPP CONGRESS 2022 3RD CONGRESS OF THE INTERNATIONAL SOCIETY FOR THE STUDY OF PLEURA AND PERITONEUM
Articles in the same Issue
- Frontmatter
- Review
- Determining a minimum data set for reporting clinical and radiologic data for pseudomyxoma peritonei
- Research Articles
- Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study
- A study of somatic BRCA variants and their putative effect on protein properties in malignant mesothelioma
- Survival benefits with EPIC in addition to HIPEC for low grade appendiceal neoplasms with pseudomyxoma peritonei: a propensity score matched study
- Histological tumor response predicts clinical outcome in patients with colorectal peritoneal metastasis treated with preoperative chemotherapy followed by cytoreduction and HIPEC
- Congress Abstracts
- ISSPP CONGRESS 2022 3RD CONGRESS OF THE INTERNATIONAL SOCIETY FOR THE STUDY OF PLEURA AND PERITONEUM
